Absci is a drug and target discovery company. Co. develops an integrated drug creation platform by merging deep learning artificial intelligence (AI) and synthetic biology. The integrated drug creation platform enables target identification, and parallel discovery of biologics and with production cell lines by incorporating biodiversity, high-throughput single cell single cell assays, and deep learning AI models. Co. uses its platform to predict, identify, design, construct, screen, select and scale production of biologic drug candidates for its partners, and Co. learns from the data it generates. Co.'s designs are AI-informed and its technology platform is scaffold-agnostic. We show 4 historical shares outstanding datapoints in our ABSI shares outstanding history coverage, used to compute ABSI market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ABSI market cap history over the course of time is important for investors
interested in comparing ABSI's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ABSI versus a peer is one thing; comparing
ABSI market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ABSI can fluctuate over the course of history.
With this page we aim to empower investors researching ABSI by allowing them to research the ABSI market cap history. |